Differences in degree of trapping of low-affinity uncompetitive N- methyl-D-aspartic acid receptor antagonists with similar kinetics of block

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 204-210

  Mealing, Geoff A R ^a   Lanthorn, T H ^a,b   Murray, C L ^a   Small, D L ^a   Morley, P ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b Astra Arcus USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; AMANTADINE; AMINOACRIDINE; DIZOCILPINE; KETAMINE; LANICEMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; MEMBRANE CURRENT; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0032934209     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Benveniste M and Mayer M (1995) Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine. J Physiol 483:367-384.
2. Black MA, Tremblay R, Mealing G, Ray R, Durkin JP, Whitfield JF, Blosser J and Morley P (1995) N-Methyl-D-aspartate- or glutamate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. J Neurochem 65:2170-2177.
3. Blanpied TA, Boeckman FA, Aizenman E and Johnson JW (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77:309-323.
4. Chen HV and Lipton S (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol 499: 27-46.
5. Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE and Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated toxicity. J Neurosci 12:4427-4435.
6. Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao M, McCarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML and Palmer GC (1997) [(S)-α-Phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartate antagonist, is effective in rodent models of global and focal ischemia. J Pharmacol Exp Ther 283:1412-1424.
7. Ginski MJ and Witkin JM (1994) Sensitive and rapid behavioural differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology 114:573-582.
8. Gurney AM and Rang HP (1984) The channel blocking action of methonium compounds on rat submandibular ganglion cells. Br J Pharmacol 82:623-642.
9. Harris E (1995) Subtypes of glutamate receptors: Pharmacological classification, in CNS Neurotransmitters and Neuromodulators: Glutamate (Stone TW ed) pp 95-125, CRC Press, New York.
10. Huettner JE and Bean BP (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant (+)-MK-801: selective binding to open channels. Proc Natl Acad Sci USA 86:1307-1311.
11. Jones SJ and Rogawski MA (1992) The anticonvulsant (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) selectively blocks NMDA-activated current in cultured rat hippocampal neurones: Kinetic analysis and comparison with dizocilpine. Mol Neuropharmacol 2:303-310.
12. Kemp JA, Foster AC and Wong EHF (1987) Non-competetive antagonists of excitatory amino acid receptors. Trends Neurosci 16:527-532.
13. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delany R, Bremner JD, Heninger GR, Bowers MB Jr and Charney DS (1994) Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: Psychomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
14. Lingle C (1983) Different types of blockade of crustacean acetylcholine-induced currents. J Physiol 339:419-437.
15. MacDonald JF, Miljkovic Z and Pennefether P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58:251-266.
16. Mealing GAR, Lanthorn TH, Small DL, Black MA, Laferriere NB and Morley P (1997) Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL 15896AR. J Pharmacol Exp Ther 281:376-383.
17. Monaghan DT and Larsen H (1997) NR1 and NR2 Subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280:614-620.
18. Muller WE, Mutschler E and Riederer P (1995) Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry 28:113-124.
19. Olney JW, Labruyere J and Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
20. Orser BA, Pennefather PS and MacDonald JF (1997) Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 86:903-917.
21. Palmer GC, Miller JA, Cregan EF, Gendron P and Peeling J (1997) Low-affinity NMDA receptor antagonists: The neuroprotective potential of ARL 15896AR. Ann NY Acad Sci 825:220-231.
22. Palmer GC, Murray RJ and McCarthy DJ (1996) Neuroprotective potential of the low affinity NMDA receptor antagonist ARL 15896AR, in Advances in the Understanding of Therapy of Ischemic Stroke, 2nd ed (Savage LM ed) pp 34-64, IBC Biomedical Library Series, Southborough, MA.
23. Parsons CG, Gruner R, Rozental J, Millar J and Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantme (1-amino-3,5-dimethyladmantan). Neuropharmacotogy 32:1337-1350.
24. Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY and Krishtal OA (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur J Neurosci 8:446-454.
25. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S and Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1238-1258.
26. Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325-331.
27. Rogawski MA, Lee DQ, Uyakul D, Pannell L, Subramaniam S, Yamaguchi S and Kokate TG (1995) Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice. Epilepsia 36:566-571.
28. Rogawski MA, Yamaguchi S, Blake PA, Jones SM, Bieda M, De Costa BR and Thurkauf A (1991) Anticonvulsant 1-phenylcycloalkylamine analogs: uncompetitive NMDA antagonists with low motor toxicity, in Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection? (Kamenka J-M and Domino EF eds) pp 747-758, NPP Books, Ann Arbor, MI.